Pharsight

Drugs that contain Docetaxel

1. Docetaxel patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10842770 SHILPA Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
Aug, 2031

(7 years from now)

US9763880 SHILPA Non-aqueous taxane formulations and methods of using the same
Sep, 2033

(9 years from now)

US8940786 SHILPA Non-aqueous taxane nanodispersion formulations and methods of using the same
Sep, 2033

(9 years from now)

US9308195 SHILPA Non-aqueous taxane formulations and methods of using the same
Sep, 2033

(9 years from now)

Market Authorisation Date: 22 December, 2015

Treatment: Method of administering docetaxel to a subject combining the docetaxel pro-emulsion formulation with an aqueous medium to produce docetaxel emulsion; Treatment of patients with locally advanced or met...

Dosage: INJECTABLE;INJECTION

More Information on Dosage

DOCETAXEL family patents

Family Patents

2. Docetaxel patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10398785 MERIDIAN LABS Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use
Mar, 2036

(12 years from now)

Market Authorisation Date: 22 November, 2022

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage

DOCETAXEL family patents

Family Patents